Aurora Cannabis Inc. - Common Shares (ACB)

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Cramer says Cerence is a winner and Aurora Cannabis is a nice speculative stock. He recommends owning NVIDIA over Skyworks. Sezzle's had its day. Build-A-Bear's results beat expectations. Republic Services is a great stock. HighPeak Energy is levered to oil prices.

Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth.

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space.

Germany's cannabis access surges with 2,500 pharmacies and 211 grow clubs, but bans on edibles and retail sales still limit the market's full potential.

Lounges legalized, markets shift, DEA hedges on reform. Catch up on this week's key cannabis news in policy, business and science.